IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
A Comparison of Changes in Bone Density With the Same Bone-health Plan, But With Different Bone-health Supplements
This study has been completed.
Sponsor:
Integrative Health Technologies, Inc.
Collaborator:
AlgaeCal Inc.
Information provided by:
Integrative Health Technologies, Inc.
ClinicalTrials.gov Identifier:
NCT01114685
First received: April 19, 2010
Last updated: April 30, 2010
Last verified: April 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
A comparison of changes in bone density following the same bone-health plan, but with a different bone-health supplement.
| Condition | Intervention |
|---|---|
| Osteopenia | Dietary Supplement: AlgaeCal-1 Dietary Supplement: AlgaeCal-2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Bone Mineral Density (BMD) Changes in a Bone Health Plan Using Two Versions of a Bone Health Supplement: A Comparative Effectiveness Research (CER) Study |
Resource links provided by NLM:
Further study details as provided by Integrative Health Technologies, Inc.:
Primary Outcome Measures:
- Changes in Bone Mineral Density (BMD) [ Time Frame: baseline and 6 months ]Measurements of bone mineral density were conducted at baseline and 6 months from baseline in two different study groups following the same bone-health behavior modification plan, but with different versions of a bone-health calcium supplement.
Secondary Outcome Measures:
- A comparison of changes from baseline in 43-blood chemistry panel and a self-reported quality of life inventory in both study groups [ Time Frame: six months ]Study subjects in both arms of the study completed a fasting 43-blood chemistry panel and an 84-item self-reported quality of life inventory at baseline and again after participating in the study for six months. No significant differences were found in the within-group changes from baseline or between the groups on both sets of measures.
| Enrollment: | 354 |
| Study Start Date: | June 2006 |
| Study Completion Date: | March 2010 |
| Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Effects of taking AlgaeCal-1
Following a bone health plan with Algae-cal-1 supplement
|
Dietary Supplement: AlgaeCal-1
Daily consumption of 7 capsules containing bone health ingredients
|
|
Active Comparator: Effects of taking AlgaeCal-2
Following a bone-health plan while consuming AlgaeCal 2
|
Dietary Supplement: AlgaeCal-2
Taking 7 capsules a day for six months
|
Detailed Description:
The US Surgeon General's Report on Bone Health suggests America's bone-health is in jeopardy and issued a "call to action" to develop bone-health plans that:
- improve nutrition,
- increase health literacy and,
- increase physical activity.
The purpose of this study was to use a comparative effective research model to compare 6-month changes in bone mineral density (BMD)in two study groups. Both followed the same bone health plan that contained the three components listed above with the same plant-source calcium supplement, but enhanced with different levels of calcium, vitamin D3, vitamin K and magnesium.
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- All subjects were required to contact the physicians to ensure they had no medical issues that would preclude their participation.
Exclusion Criteria:
- Younger the 18 years of age, and
- Recommendations not to participate from their physicians.
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01114685
Please refer to this study by its ClinicalTrials.gov identifier: NCT01114685
Locations
| United States, Texas | |
| Integrative Health Technologies | |
| San Antonio, Texas, United States, 78209 | |
Sponsors and Collaborators
Integrative Health Technologies, Inc.
AlgaeCal Inc.
Investigators
| Principal Investigator: | Gilbert R Kaats, PhD | Integrative Health Technologies |
| Principal Investigator: | Harry G Preuss, MD | Georgetown University |
More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Gilbert R. Kaats, PhD, Integrative Health Technologies, Inc. |
| ClinicalTrials.gov Identifier: | NCT01114685 History of Changes |
| Other Study ID Numbers: |
AlgaeCal 1 & 2 |
| Study First Received: | April 19, 2010 |
| Last Updated: | April 30, 2010 |
Additional relevant MeSH terms:
|
Bone Diseases, Metabolic Bone Diseases Musculoskeletal Diseases |
ClinicalTrials.gov processed this record on July 25, 2017